 Diminution inducible lymphokine-activated killer cell activity individuals AIDS-related disorders relative ability lymphokine-activated killer LAK cells peripheral blood HIV-seropositive people AIDS subjects healthy controls panel natural killer NK NK-resistant tumor virally-infected targets LAK cells HIV-seropositive populations significant capacity RAJI target cell lines comparison cells healthy controls reductions LAK activity HIV-seropositive asymptomatic AIDS populations significant reduction cytotoxic potential individual LAK cells maximal LAK cytotoxic potentials control asymptomatic seropositive AIDS populations comparable LAK cells HIV-seropositive populations enhanced capacity HIV-infected targets uninfected counterparts enhancements HIV-infected versus cytolysis arise increases maximal cell-mediated cytolytic plateau Depletion NK peripheral blood LAK cell generation subsequent specific total inducible LAK activity subjects peripheral blood T-cell depletion LAK cell generation results LAK cells cytolytic activity whereas subjects similar T-cell depletion impairs inducible LAK cell responses